(Q34275917)

English

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Epstein–Barr virus

0 references

organ transplantation

1 reference

based on heuristic

inferred from title

1

object named as

Green M

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Reyes J

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Webber S

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Rowe D

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

97-103

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preemptive Therapy in Immunocompromised Hosts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplant Lymphoproliferative Disease in Primary Epstein‐Barr Virus Infection after Liver Transplantation: The Role of Cytomegalovirus Disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretransplantation assessment of the risk of lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Intravenous Ganciclovir Followed by Oral Acyclovir with Intravenous Ganciclovir Alone for Prevention of Cytomegalovirus and Epstein‐Barr Virus Disease After Liver Transplantation in Children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-3062.2001.003002097.X

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34275917&oldid=2041885906"